Mezzion Pharma Co.,Ltd.

Informe acción KOSDAQ:A140410

Capitalización de mercado: ₩1.2t

Mezzion PharmaLtd Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Dean Park

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO6.5%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

Optimistic Investors Push Mezzion Pharma Co.,Ltd. (KOSDAQ:140410) Shares Up 26% But Growth Is Lacking

Mar 04
Optimistic Investors Push Mezzion Pharma Co.,Ltd. (KOSDAQ:140410) Shares Up 26% But Growth Is Lacking

We Might See A Profit From Mezzion Pharma Co.,Ltd. (KOSDAQ:140410) Soon

Feb 05
We Might See A Profit From Mezzion Pharma Co.,Ltd. (KOSDAQ:140410) Soon

Mezzion PharmaLtd (KOSDAQ:140410) Shareholders Have Enjoyed A Whopping 605% Share Price Gain

Dec 14
Mezzion PharmaLtd (KOSDAQ:140410) Shareholders Have Enjoyed A Whopping 605% Share Price Gain

CEO

Dean Park (67 yo)

no data

Permanencia

Mr. Dong Hyun Park, Dean is the Founder of Mezzion Pharma Co.,Ltd. (formerly known as Dong-A PharmTech Co. Ltd.) and also serves as its Chief Executive Officer and President. Mr. Park also founded and serv...